BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 28, 2003
View Archived Issues
Fourth Approval For Enbrel: Amgen Adds Spinal Arthritis
As expected, Amgen Inc. and Wyeth Pharmaceuticals won marketing clearance from the FDA for Enbrel (etanercept) against ankylosing spondylitis, or arthritis of the spine. (BioWorld Today)
Read More
Vertex Still Expects Approval Of 908 Despite Missed Main Endpoint
Read More
Pain Perception Arises In Remote Region Of Brain's Cerebral Cortex; Gene Therapy Trial Back-Burnered
Read More
House Passes Bill That Would Allow Reimportation Of Drugs
Read More
Chiron Sells $450M In Notes To Replenish Cash Position
Read More
Roche Secures Rights To Origen Via $1.4B Purchase From IGEN
Read More
Other News To Note
Read More
Appointments And Advancements
Read More